I am a research analyst. I am currently working on a project which deals with the biopharmaceutical contract manufacturing organization (cmo) market. The following are the deliverable that need to be addressed.
- cost model for monoclonal antibody manufacturing by a cmo or biopharmaceutical company.
- global mammalian and microbial drug manufacturing capacities.
- capacity of cmos and that of biopharma companies
- capacity of mammalian and microbial cell culture manufacturing by region+22 Other Responses
Biopharma Functional Services
I am trying to understand functional services for biopharma, such as pharmacovigilance, medical writing, biostats, data management & reporting, regulatory doc submission etc, that cros and bpos provide. Interested in payment models, billing practices, wages and most importantly how pharma companies are working with providers in this area.+23 Other Responses
Supply Chain Best Practices In Biopharma
I am writing on behalf of a consulting firm that conducts expert interviews in support of industry-wide studies for many of the world's fortune 1000 companies. We help businesses answer questions by engaging with the world’s most relevant experts. So far we have delivered over 1000 studies with input from over 18,000 individuals. We are an authorized zintro partner.
For a current study, we are seeking to speak with experts who can share insights around the impact that potential us tax system changes might have on the bio-pharma manufacturing sector. More specifically, our client assumes that the new trump administration in the us will incur major changes in tax systems (e.G. Corporate tax cut, tax exemption over export products, etc.). We are seeking to understand what would be the key changes, resulting from that, or key impacts over bio-pharma in-house or outsourcing strategy. Please note that we would only consider us- or europe-based experts with recent experience and who can provide shared learnings from one or more of the following companies:
1st priority: j&j, bms, pfizer, abbvie, amgen
2nd priority: roche/genentech, novartis, astrazeneca
please note that we are only interested in your personal point of view and expert insight and are not seeking any confidential information.
We would welcome any referrals to other relevant experts as well.
vlady+undefined Other Responses
Business Development In Biotechnology
We are looking for a business expert to help with business development and negotiation in a fast growing biotechnology company in northern california.
experience in biotechnological company and global sustainability, extensive global experience for growth and deployment.Experience in applying innovation and creativity to business development, negotiation and building alliances within the biotechnology, pharmaceutical
areas of expertise:
seeking experts with knowledge of business development in biotech; biotechnology and catapult the company into the next growth phase
note: since we look for a long tern relationship with qualified business expert, the phone interview would be required. Thanks.+39 Other Responses